Immunofluorescence staining for CD68 and Iba1 revealed increased microglial activation in the PBS-treated epilepsy group, which was significantly attenuated following L. eligens administration (Figure 5E-F), indicating suppression of neuroinflammatory microglial responses. The gene discussed is CD68; the disease is epilepsy.